600998 九州通
已收盘 12-19 15:00:00
资讯
新帖
简况
平安证券“上市公司价值发现之旅”武汉站,走进全国最大民营医药流通企业九州通
全景财经 · 20:53
平安证券“上市公司价值发现之旅”武汉站,走进全国最大民营医药流通企业九州通
九州通不动产证券化再进一步,高额债务压力待解
新京报 · 12-18 21:42
九州通不动产证券化再进一步,高额债务压力待解
九州通(600998.SH)拟转让医药仓储物流基础设施公募REITs资产相关项目公司股权
智通财经网 · 12-17 19:51
九州通(600998.SH)拟转让医药仓储物流基础设施公募REITs资产相关项目公司股权
九州通(600998.SH)拟转让医药仓储物流Pre-REITs项目入池资产相关公司股权
智通财经 · 12-17 19:48
九州通(600998.SH)拟转让医药仓储物流Pre-REITs项目入池资产相关公司股权
九州通最新公告:拟转让医药仓储物流Pre-REITs项目入池资产相关公司股权
证券之星 · 12-17 19:40
九州通最新公告:拟转让医药仓储物流Pre-REITs项目入池资产相关公司股权
九州通(600998.SH)完成回购1.11%股份 耗资2.68亿元
智通财经 · 12-17 18:30
九州通(600998.SH)完成回购1.11%股份 耗资2.68亿元
九州通:累计回购5603.65万股
每日经济新闻 · 12-17 18:03
九州通:累计回购5603.65万股
中邮证券:给予九州通买入评级
证券之星 · 12-16
中邮证券:给予九州通买入评级
九州通与关联方交易2025年度预计金额不超21.06亿元
财中社 · 12-09
九州通与关联方交易2025年度预计金额不超21.06亿元
九州通12月04日主力资金流出1425万元 连续3日减仓
市场透视 · 12-04
九州通12月04日主力资金流出1425万元 连续3日减仓
九州通12月03日遭主力抛售2485万元 环比增加150.76%
市场透视 · 12-03
九州通12月03日遭主力抛售2485万元 环比增加150.76%
九州通Pre-REITs+公募REITs:挖掘医药仓储资产新价值 实现向轻资产运营转型
中国财富通 · 11-28
九州通Pre-REITs+公募REITs:挖掘医药仓储资产新价值 实现向轻资产运营转型
1-10月医保统筹收入稳增长,机构:医药后市反转源于三大机会
汇添富基金 · 11-28
1-10月医保统筹收入稳增长,机构:医药后市反转源于三大机会
《新股》九源基因(02566.HK)公开发售超购近675倍 一手中签率20%
阿斯达克财经 · 11-28
《新股》九源基因(02566.HK)公开发售超购近675倍 一手中签率20%
欠债百亿的九州通业绩不佳,何以翻身?
医深观 · 11-26
欠债百亿的九州通业绩不佳,何以翻身?
九州通:公司医药物流仓储资产Pre-REITs项目进展顺利
每日经济新闻 · 11-21
九州通:公司医药物流仓储资产Pre-REITs项目进展顺利
九州通:公司已立项实施数字化转型项目40个,其中32个项目已经上线推广
每日经济新闻 · 11-21
九州通:公司已立项实施数字化转型项目40个,其中32个项目已经上线推广
【企业动态】九州通新增3件法院诉讼
证券之星 · 11-21
【企业动态】九州通新增3件法院诉讼
九源基因招股,引入复星、阿里健康、健友股份、九州通等7名基石投资者,11月28日香港上市
市场资讯 · 11-20
九源基因招股,引入复星、阿里健康、健友股份、九州通等7名基石投资者,11月28日香港上市
【企业动态】九州通新增5件法院诉讼
证券之星 · 11-20
【企业动态】九州通新增5件法院诉讼
加载更多
公司概况
公司名称:
九州通医药集团股份有限公司
所属行业:
批发业
上市日期:
2010-11-02
主营业务:
九州通医药集团股份有限公司的主营业务包括数字化医药分销与供应链业务、总代品牌推广业务、医药工业自产及OEM业务、医药新零售与万店加盟业务、医疗健康与技术增值服务、数字物流技术与供应链解决方案六大方面。公司的主要产品为西药、中成药、中药材、中药饮片、医疗器械、计生用品、食品、保健品、化妆品。公司是国内最大的民营医药商业企业,位列中国医药商业企业第四位。公司是行业内唯一获评全国十大“国家智能化仓储物流示范基地”的企业,位列2023年《财富》“中国企业500强”第171位、“中国民营企业500强”第57位。
发行价格:
13.00
{"stockData":{"symbol":"600998","market":"SH","secType":"STK","nameCN":"九州通","latestPrice":5.4,"timestamp":1734591600000,"preClose":5.42,"halted":0,"volume":20660367,"delay":0,"floatShares":5042000000,"shares":5042000000,"eps":0.4059,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.02,"latestTime":"12-19 15:00:00","open":5.39,"high":5.41,"low":5.3,"amount":111000000,"amplitude":0.0203,"askPrice":5.41,"askSize":1275,"bidPrice":5.4,"bidSize":765,"shortable":0,"etf":0,"ttmEps":0.4059,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734658200000},"adr":0,"adjPreClose":5.42,"symbolType":"stock","openAndCloseTimeList":[[1734571800000,1734579000000],[1734584400000,1734591600000]],"highLimit":5.96,"lowLimit":4.88,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":5042470234,"pbRate":1.1,"roa":"--","roe":"7.07%","epsLYR":0.55,"committee":-0.083417,"marketValue":27229000000,"floatMarketCap":27229000000,"peRate":13.303769,"changeRate":-0.0037,"turnoverRate":0.0041,"status":1},"requestUrl":"/m/hq/s/600998","defaultTab":"news","newsList":[{"id":"2492173792","title":"平安证券“上市公司价值发现之旅”武汉站,走进全国最大民营医药流通企业九州通","url":"https://stock-news.laohu8.com/highlight/detail?id=2492173792","media":"全景财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492173792?lang=zh_cn&edition=full","pubTime":"2024-12-19 20:53","pubTimestamp":1734612804,"startTime":"0","endTime":"0","summary":"11月26日,平安证券“研途有你 财富同行”上市公司价值发现之旅·武汉站,走进全国最大的民营医药流通企业九州通[1]。刘志峰介绍,九州通成立于2000年,成立之初,公司业务以药品分销为主,经过多年发展,目前公司已发展成为涵盖医药流通、医药代理、医药工业、新零售等多业态的,全国最大的民营医药流通企业。未来,平安证券将继续携手高净值客户,探索更多上市公司的价值,发现更多投资机会。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219205937ab8473e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219205937ab8473e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159938","BK0250","BK0146","161027","BK0201","BK0077","BK0187","BK0039","BK0012","BK0183","BK0188","600998","BK0196","BK0097","BK0028"],"gpt_icon":0},{"id":"2492216303","title":"九州通不动产证券化再进一步,高额债务压力待解","url":"https://stock-news.laohu8.com/highlight/detail?id=2492216303","media":"新京报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492216303?lang=zh_cn&edition=full","pubTime":"2024-12-18 21:42","pubTimestamp":1734529332,"startTime":"0","endTime":"0","summary":"九州通表示,此次减资事项主要是为满足财务公司设立的需求。本次交易完成后,九州通将不再持有标的公司股权。今年9月,中国证监会和上海证券交易所受理九州通首个公募REITs项目,入池资产为武汉市东西湖区医药物流仓储基地。作为四大药商中唯一一家民营企业,九州通看似风光的背后还面临高额债务压力。九州通总负债为682.07亿元,较去年同期增长5.53%,其中应付账款195.36亿元。今年前三季度,九州通经营活动现金流净流出约26.58亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218214534a1f8ab60&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218214534a1f8ab60&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0183","BK0187","BK0028","BK0097","BK0196","BK0188","BK0039","BK0077","600998","BK0012","BK0250","BK0201","BK0146"],"gpt_icon":0},{"id":"2492953179","title":"九州通(600998.SH)拟转让医药仓储物流基础设施公募REITs资产相关项目公司股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2492953179","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492953179?lang=zh_cn&edition=full","pubTime":"2024-12-17 19:51","pubTimestamp":1734436261,"startTime":"0","endTime":"0","summary":"九州首瑞持有基础设施公募REITs底层资产即武汉东西湖项目,截至2024年6月30日,武汉东西湖项目不动产评估值为10.98亿元,基础设施公募REITs拟募集资金金额11.11亿元。本次交易完成后,公司将不再持有九州首瑞股权,九州首瑞将不再纳入公司合并报表范围。同时,九州通物流或其同一控制下的相关方拟参与基础设施公募REITs份额的战略配售,认购占本次基金份额发售数量34%的份额,拟认购出资金额约为3.78亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1226154.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0097","BK0187","BK0012","BK0250","BK0077","BK0183","BK0196","BK0188","600998","CFA","BK0039","BK0201","BK0146","09939","BK1515","159938","CFA.SI","BK1161","BK0028","BK1574"],"gpt_icon":0},{"id":"2492535479","title":"九州通(600998.SH)拟转让医药仓储物流Pre-REITs项目入池资产相关公司股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2492535479","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492535479?lang=zh_cn&edition=full","pubTime":"2024-12-17 19:48","pubTimestamp":1734436101,"startTime":"0","endTime":"0","summary":"智通财经APP讯,九州通(600998.SH)发布公告,因医药仓储物流Pre-REITs项目发行的需要,公司全资孙公司上海骏英达、浙江九州通及重庆九州通拟分别向上海和稳、杭州和隽及重庆和昱转让其持有的上海通达、杭州卓英堂及重庆首瑞100%股权。本次交易标的公司上海通达、杭州卓英堂及重庆首瑞分别持有公司Pre-REITs项目首期入池资产,即位于上海、杭州及重庆的三处医药仓储物流资产及配套设施,合计总建筑面积约为24万平方米。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1226153.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0188","BK0250","BK0196","CFA","BK0028","09939","BK0012","BK1515","BK0077","600998","159938","BK0183","BK0187","BK1161","BK0097","BK0146","BK0039","BK1574","BK0201"],"gpt_icon":0},{"id":"2492958069","title":"九州通最新公告:拟转让医药仓储物流Pre-REITs项目入池资产相关公司股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2492958069","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492958069?lang=zh_cn&edition=full","pubTime":"2024-12-17 19:40","pubTimestamp":1734435612,"startTime":"0","endTime":"0","summary":"九州通公告,公司全资孙公司上海骏英达供应链管理有限公司、浙江九州通医药有限公司、重庆九州通医药有限公司拟分别向上海和稳企业管理有限公司、杭州和隽企业管理有限公司、重庆和昱企业管理有限公司转让其持有的上海九州通达医药有限公司、杭州卓英堂瑞施供应链管理有限公司、重庆九州首瑞供应链服务有限公司100%股权。本次交易的股权转让价格总额预计为人民币不超过17.00亿元。本次交易完成后,公司将不再持有标的公司股权,标的公司将不再纳入公司合并报表范围。本次交易不构成关联交易,不构成重大资产重组。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121700034076.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600998","BK1574","159938","BK0187","BK0097","BK0188","BK0039","BK0146","BK0250","BK1515","BK0077","BK0201","09939","BK0196","BK0028","BK1161","BK0012","BK0183"],"gpt_icon":0},{"id":"2492934722","title":"九州通(600998.SH)完成回购1.11%股份 耗资2.68亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492934722","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492934722?lang=zh_cn&edition=full","pubTime":"2024-12-17 18:30","pubTimestamp":1734431407,"startTime":"0","endTime":"0","summary":"智通财经APP讯,九州通(600998.SH)公告,截至2024年12月16日,公司回购期限届满,公司累计回购股票5603.65万股,占公司总股本的比例为1.11%,回购的最高价为5.49元/股、最低价为4.42元/股,回购均价为4.78元/股,已支付的总金额为2.68亿元(不含佣金、手续费)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1226064.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0201","BK0097","BK0077","BK0028","BK0012","BK0196","BK0250","BK0146","600998","BK0188","BK0183","BK0187","BK0039"],"gpt_icon":0},{"id":"2492953202","title":"九州通:累计回购5603.65万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2492953202","media":"每日经济新闻","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492953202?lang=zh_cn&edition=full","pubTime":"2024-12-17 18:03","pubTimestamp":1734429835,"startTime":"0","endTime":"0","summary":"每经AI快讯,九州通 12月17日晚间发布公告称,截至2024年12月16日,本次回购期限届满,公司累计回购股票5603.65万股,占公司总股本的比例为1.11%,回购的最高价为5.49元/股、最低价为4.42元/股,回购均价为4.78元/股,已支付的总金额约为2.68亿元。2024年1至6月份,九州通的营业收入构成为:医药批发及相关业务占比96.04%,医药零售占比1.89%,医药工业占比1.86%,医疗健康及技术服务占比0.13%,其他业务占比0.08%。截至发稿,九州通市值为274亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217180454ab7eceee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217180454ab7eceee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0012","BK0028","BK0077","BK0039","BK0146","BK0196","BK0187","600998","BK0201","BK0183","BK0250","BK0188","BK0097"],"gpt_icon":0},{"id":"2491506596","title":"中邮证券:给予九州通买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2491506596","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491506596?lang=zh_cn&edition=full","pubTime":"2024-12-16 17:32","pubTimestamp":1734341562,"startTime":"0","endTime":"0","summary":"中邮证券有限责任公司蔡明子,龙永茂近期对九州通进行研究并发布了研究报告《REITs赋能协同共赢,“双上市”估值重塑》,本报告对九州通给出买入评级,当前股价为5.48元。原始权益人九州通物流拟认购基金份额34%,保障项目的稳定运营。最新盈利预测明细如下:该股最近90天内共有10家机构给出评级,买入评级9家,增持评级1家;过去90天内机构目标均价为6.54。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121600024745.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","600998"],"gpt_icon":0},{"id":"2490774096","title":"九州通与关联方交易2025年度预计金额不超21.06亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490774096","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490774096?lang=zh_cn&edition=full","pubTime":"2024-12-09 18:46","pubTimestamp":1733741183,"startTime":"0","endTime":"0","summary":"2024年度公司与主要关联方的关联交易预计全年金额不超过26.13亿元,而2024年1月至10月实际发生关联交易为14.09亿元。所有关联交易均按照市场价格协商定价,不会影响公司的独立性和持续经营能力。2024年前三季度,九州通实现收入1134.29亿元,归母净利润16.96亿元。文章来源:财中社九州通与关联方交易2025年度预计金额不超21.06亿元","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209185003ab699723&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209185003ab699723&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0097","BK0039","BK0077","BK0183","BK0201","BK0028","BK0187","BK0146","BK0012","BK0196","BK0188","BK0250","600998"],"gpt_icon":0},{"id":"2488153964","title":"九州通12月04日主力资金流出1425万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2488153964","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488153964?lang=zh_cn&edition=full","pubTime":"2024-12-04 15:19","pubTimestamp":1733296755,"startTime":"0","endTime":"0","summary":"12月04日, 九州通股价跌2.21%,报收5.30元,成交金额1.57亿元,换手率0.59%,振幅2.77%,量比1.00。九州通今日主力资金净流出1425万元,连续3日净流出,上一交易日主力净流出2485万元,今日环比减少42.66%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为50.00%,平均跌幅为1.18%。该股近5个交易日下跌0.56%,主力资金累计净流出4309万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出9071万元,其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204153102abf4e400&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204153102abf4e400&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0012","BK0039","BK0028","BK0077","BK0183","BK0146","BK0188","BK0250","BK0196","BK0201","BK0097","BK0187","600998"],"gpt_icon":0},{"id":"2488796405","title":"九州通12月03日遭主力抛售2485万元 环比增加150.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488796405","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488796405?lang=zh_cn&edition=full","pubTime":"2024-12-03 15:21","pubTimestamp":1733210515,"startTime":"0","endTime":"0","summary":"12月03日, 九州通股价跌0.55%,报收5.42元,成交金额1.45亿元,换手率0.53%,振幅2.02%,量比0.96。九州通今日主力资金净流出2485万元,上一交易日主力净流出991万元,今日环比增加150.76%。该股近5个交易日上涨4.63%,主力资金累计净流出2308万元;近20日主力资金累计净流出7920万元,其中净流出天数为12日。净流出前三个股分别为中国医药、九州通、漱玉平民。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203154312a268abf8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203154312a268abf8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0250","BK0201","BK0196","BK0097","BK0077","BK0146","BK0012","600998","BK0183","BK0187","BK0028","BK0039","BK0188"],"gpt_icon":0},{"id":"2486398703","title":"九州通Pre-REITs+公募REITs:挖掘医药仓储资产新价值 实现向轻资产运营转型","url":"https://stock-news.laohu8.com/highlight/detail?id=2486398703","media":"中国财富通","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486398703?lang=zh_cn&edition=full","pubTime":"2024-11-28 09:57","pubTimestamp":1732759057,"startTime":"0","endTime":"0","summary":"对于上述资本运作,九州通表示,公司成立Pre-REITs基金主要为公募REITs未来扩募孵化和培育优质的医药物流仓储资产,助力公司快速实现不动产证券化战略转型。目前,九州通医药仓储公募REITs项目已在问询反馈中。九州通通过Pre-REITs与公募REITs的发行上市,有望显著提升公司所持优质医药物流仓储资产的公允价值,进而提升公司的市场价值,实现九州通和公募REITs“双上市”平台的协同共赢。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://irb.cfbond.com/api/v1/detail.html?newsid=W9LgUzB6A74%3D","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0012","BK0183","BK0250","BK1515","09939","CFA","BK0187","BK0146","159938","BK1574","600998","BK0077","BK1161","BK0097","BK0039","BK0028","BK0201","BK0196","BK0188"],"gpt_icon":0},{"id":"2486387128","title":"1-10月医保统筹收入稳增长,机构:医药后市反转源于三大机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2486387128","media":"汇添富基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486387128?lang=zh_cn&edition=full","pubTime":"2024-11-28 08:11","pubTimestamp":1732752682,"startTime":"0","endTime":"0","summary":"消息面上,据医保局日前披露,2024年1-10月医保统筹基金收入23065.07亿元,同比增长8.9%;2024年1-10月统筹支出19165.88亿元,同比增长8.9%。对此,国泰君安表示,1-10月医保统筹基金运行平稳,收入稳健增长,支出增速逐月收窄。国金证券表示,由于多方面因素,医药板块景气度在2021年后经历了长时间的下行。2024年11月7日,国家医保局召开了座谈会,强调了全国统一医保平台和大数据赋能商保发展的重要性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112807590598e4504f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112807590598e4504f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600721","603108","BK0185","688163","603087","600976","600351","603858","600436","603939","688575","600380","600998","688331","603309","688266","600200","688278","600055","605199","603392","600161","600521","BK0070","600572","688192","688276","603439","600771","688506","688315","603567","600511","BK0096","688298","688356","600329","688193","600332","688581","688180","688336","600851","688076","688139","688198","600196","603127","600085","600129","688656","600080","603301","603658","600566","688373","688189","688067","605177","BK0012","600867","688221","688050","688488","688578","688687","688212","688105","688301","688670","600056","688046","688382","688091","688389","603456","688062","688085","603707","688566","600739","688235","688247","688428","600079","600062","688520","600763","603882","BK0239","688177","159938","603259","600252","603538","603896","688029","600420","688117","688658","688073","688351","BK0188","688222","688137","601607","688202","603590","600422","600535","688626","BK0028","688114","688176","600529","688690","600276","688443","600211","600285","688617","688767","688271","688321","688166","603367","603233","688161","600488"],"gpt_icon":0},{"id":"2486806278","title":"《新股》九源基因(02566.HK)公开发售超购近675倍 一手中签率20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486806278","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486806278?lang=zh_cn&edition=full","pubTime":"2024-11-28 03:20","pubTimestamp":1732735200,"startTime":"0","endTime":"0","summary":"九源基因公布招股结果,公开发售接获675.83倍认购,一手中签率20.01%,认购4,000股获稳派一手。按回拨机制,公开发售股份已增至2,269.94万股,占发售总数50%。股份预期周四挂牌。中国生物制药公司九源基因是次全球发售4,539.88万股,香港发售原占10%;招股价介乎11.48-12.56元。七名基石投资者包括︰和达香港、复星医药旗下复星实业、健友股份旗下香港健友、阿里健康旗下阿里健康香港、九州通旗下Jointown International、君亭酒店创办人吴启元及Delta Capital HK,合共认购3.5亿元公司股份。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20241126155516619_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20241126155516619_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1400052/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1571","BK1247","BK0239","BK0028","BK0201","BK0097","BK0039","BK1610","BK0250","BK1589","BK0187","BK0196","600998","BK0146","BK0012","BK0246","BK1591","301073","BK1593","BK0186","BK0046","BK1515","00241","BK0183","BK1142","603707","BK1191","BK1501","BK0077","BK0188","BK1189","02196","BK1584","BK1502"],"gpt_icon":1},{"id":"2486923003","title":"欠债百亿的九州通业绩不佳,何以翻身?","url":"https://stock-news.laohu8.com/highlight/detail?id=2486923003","media":"医深观","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486923003?lang=zh_cn&edition=full","pubTime":"2024-11-26 21:30","pubTimestamp":1732627830,"startTime":"0","endTime":"0","summary":"截止2023年年末,九州通来自二级及以上医院的收入占医疗机构渠道的比例已高达47.48%。但是2024年以来,九州通的业绩瞬间变脸。近年来,九州通及旗下子公司频频被曝出销售劣药被罚、虚假宣传等事件。据不完全统计,自2019年以来九州通已被国家监管部门累计处罚超千万元。除了业绩承压之外,监管不力之外,九州通还面临高额债务压力。九州通过度依赖杠杆进行扩张,容易翻船。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126214528a2572e9d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126214528a2572e9d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0250","BK0146","BK0201","BK0077","BK0187","BK0039","BK0012","BK0183","BK0188","600998","BK0196","BK0097","BK0028"],"gpt_icon":0},{"id":"2485841941","title":"九州通:公司医药物流仓储资产Pre-REITs项目进展顺利","url":"https://stock-news.laohu8.com/highlight/detail?id=2485841941","media":"每日经济新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485841941?lang=zh_cn&edition=full","pubTime":"2024-11-21 23:49","pubTimestamp":1732204199,"startTime":"0","endTime":"0","summary":"九州通11月21日在投资者互动平台表示,公司医药物流仓储资产Pre-REITs项目进展顺利,公司已联合不动产私募基金管理人及相关中介机构,完成对Pre-REITs基金拟纳入资产池的尽职调查及基金方案设计。相关政府合规沟通及内部资产重组工作正在顺利推进。公司拟于近期开展Pre-REITs基金的备案及募集工作,本期Pre-REITs基金已落实基石投资人及银行贷款资金,并已确认多家机构投资人的基金认购意向,认购倍数较高。本期Pre-REITs基金将力争于2024年内完成首批资产的交割。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121235031abd50917&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121235031abd50917&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159938","BK0250","BK0146","BK0201","BK0077","BK0187","BK0039","BK0012","BK0183","BK0188","600998","BK0196","BK0097","BK0028"],"gpt_icon":0},{"id":"2485457080","title":"九州通:公司已立项实施数字化转型项目40个,其中32个项目已经上线推广","url":"https://stock-news.laohu8.com/highlight/detail?id=2485457080","media":"每日经济新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485457080?lang=zh_cn&edition=full","pubTime":"2024-11-21 17:41","pubTimestamp":1732182094,"startTime":"0","endTime":"0","summary":"数字化项目中是否涉及AI等相关技术的应用?公司已立项实施数字化转型项目40个,其中32个项目已经上线推广,项目以大数据+AI算法等为驱动,推动主营业务的在线营销、在线交易、在线支付和在线协作等。目前“骨科嫦娥”智慧系统能够自动识别并管理2000多种医疗器械,能效提升30倍,精度高达99.9%,并已迅速推广至术前、配送、术中、术后的全流程医疗场景中。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121174211abd45947&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121174211abd45947&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0077","BK0250","BK0146","BK0183","BK0188","BK0012","600998","BK0187","BK0039","BK0028","BK0201","BK0196","BK0097"],"gpt_icon":0},{"id":"2485174458","title":"【企业动态】九州通新增3件法院诉讼","url":"https://stock-news.laohu8.com/highlight/detail?id=2485174458","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485174458?lang=zh_cn&edition=full","pubTime":"2024-11-21 06:20","pubTimestamp":1732141225,"startTime":"0","endTime":"0","summary":"证券之星消息,根据企查查数据显示,11月20日九州通(600998)新增3件法院诉讼如下:案号:(2024)鄂01民终20795号法院:湖北省武汉市中级人民法院案由:买卖合同纠纷上诉人:林州万方医院、尚某某被上诉人:九州通医药集团股份有限公司案件类型:民事立案日期:2024年11月20日案号:(2024)鄂01民终20794号法院:湖北省武汉市中级人民法院案由:买卖合同纠纷上诉人:九州通医药集团股","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112100003999.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0077","BK0196","BK0183","BK0012","BK0187","BK0039","600998","BK0028","BK0146","BK0250","BK0188","BK0201"],"gpt_icon":0},{"id":"2484554161","title":"九源基因招股,引入复星、阿里健康、健友股份、九州通等7名基石投资者,11月28日香港上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2484554161","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484554161?lang=zh_cn&edition=full","pubTime":"2024-11-20 13:22","pubTimestamp":1732080120,"startTime":"0","endTime":"0","summary":" 来自浙江杭州的生物制药公司九源基因,于今日起至下周一招股,预计2024年11月28日在港交所挂牌上市,华泰国际独家保荐。 九源基因,计划全球发售4539.88万股H股,其中90%为国际发售、10%为公开发售,另有15%超额配股权,每股发售价介乎11.48港元至12.56港元,每手200股,最多募资约5.70亿港元。8款已上市产品包括骨科、肿瘤、血液领域的1款创新药械组合,2款生物制品、5款化学药品。九源基因已建立覆盖全国的销售及分销网络。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/2024-11-20/doc-incwsueq5437050.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1501","BK0188","BK0250","BK0196","BK1571","BK1189","BK1610","00241","BK0028","BK1591","BK0239","BK0012","BK1515","BK0077","600998","BK0183","BK0187","BK1247","BK1142","BK1584","BK0097","BK0046","BK0146","BK1589","BK0039","BK0186","02566","603707","BK0201","BK1502"],"gpt_icon":0},{"id":"2484350904","title":"【企业动态】九州通新增5件法院诉讼","url":"https://stock-news.laohu8.com/highlight/detail?id=2484350904","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484350904?lang=zh_cn&edition=full","pubTime":"2024-11-20 06:07","pubTimestamp":1732054037,"startTime":"0","endTime":"0","summary":"证券之星消息,根据企查查数据显示,11月19日九州通(600998)新增5件法院诉讼如下:案号:(2024)鄂01民辖终1470号法院:湖北省武汉市中级人民法院案由:其他上诉人:四川义信隆中药材贸易有限公司被上诉人:九州通医药集团股份有限公司案件类型:管辖立案日期:2024年11月19日案号:(2024)鄂0105民初13315号法院:武汉市汉阳区人民法院案由:买卖合同纠纷原告:九州通医药集团股份","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112000005956.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0012","BK0183","BK0039","BK0097","BK0146","BK0188","BK0201","BK0250","600998","BK0196","BK0028","BK0187"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2010-11-02","address":"湖北省武汉市汉阳区龙兴西街5号","stockEarnings":[{"period":"1week","weight":-0.0128},{"period":"1month","weight":0.0074},{"period":"3month","weight":0.1886},{"period":"6month","weight":0.0711},{"period":"1year","weight":0.018},{"period":"ytd","weight":0.0326}],"companyName":"九州通医药集团股份有限公司","boardCode":"AI0051","perCapita":"142009股","boardName":"批发业","registeredCapital":"504247万元","compareEarnings":[{"period":"1week","weight":-0.0146},{"period":"1month","weight":0.0176},{"period":"3month","weight":0.2362},{"period":"6month","weight":0.1281},{"period":"1year","weight":0.1534},{"period":"ytd","weight":0.1369}],"survey":" 九州通医药集团股份有限公司的主营业务包括数字化医药分销与供应链业务、总代品牌推广业务、医药工业自产及OEM业务、医药新零售与万店加盟业务、医疗健康与技术增值服务、数字物流技术与供应链解决方案六大方面。公司的主要产品为西药、中成药、中药材、中药饮片、医疗器械、计生用品、食品、保健品、化妆品。公司是国内最大的民营医药商业企业,位列中国医药商业企业第四位。公司是行业内唯一获评全国十大“国家智能化仓储物流示范基地”的企业,位列2023年《财富》“中国企业500强”第171位、“中国民营企业500强”第57位。","serverTime":1734619305879,"listedPrice":13,"stockholders":"35508人(较上一季度增加2.52%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"九州通(600998)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供九州通(600998)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"九州通,600998,九州通股票,九州通股票老虎,九州通股票老虎国际,九州通行情,九州通股票行情,九州通股价,九州通股市,九州通股票价格,九州通股票交易,九州通股票购买,九州通股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"九州通(600998)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供九州通(600998)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}